The Deal with Hefei Bio is $6.5 Million AUD no small figure. It is non-exclusive as far as i know - meaning we can take it to other world markets.
Considering their are companies on ASX that have so called medical apps that can tell you if you have the common cold and people are going nuts over. In comparison we have a viable product that can actually deliver results.
I think the deal should've been valued at a minimum $10 Mil AUD considering the R&D and trial costs alone.
PAB Price at posting:
1.0¢ Sentiment: Buy Disclosure: Held
